RASA4B
gene geneOn this page
Summary
RASA4B (RAS p21 protein activator 4B, HGNC:35202) is a protein-coding gene on chromosome 7q22.1, encoding Ras GTPase-activating protein 4B (C9J798). Ca(2+)-dependent Ras GTPase-activating protein, that may play a role in the Ras-MAPK pathway.
Predicted to enable GTPase activator activity; phospholipid binding activity; and zinc ion binding activity. Predicted to be involved in cellular response to calcium ion; intracellular signal transduction; and negative regulation of Ras protein signal transduction. Predicted to be located in cytosol and plasma membrane.
Source: NCBI Gene 100271927 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001367767
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35202 |
| Approved symbol | RASA4B |
| Name | RAS p21 protein activator 4B |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000170667 |
| Ensembl biotype | protein_coding |
| Entrez | 100271927 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 5 protein_coding, 4 retained_intron, 1 nonsense_mediated_decay
ENST00000306682, ENST00000465829, ENST00000467351, ENST00000477184, ENST00000488284, ENST00000495352, ENST00000541662, ENST00000707123, ENST00000879066, ENST00000952237
RefSeq mRNA: 2 — MANE Select: NM_001367767
NM_001277335, NM_001367767
CCDS: CCDS59506, CCDS94160
Canonical transcript exons
ENST00000465829 — 21 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002275632 | 102517646 | 102517777 |
| ENSE00003467023 | 102510179 | 102510292 |
| ENSE00003544444 | 102511925 | 102511981 |
| ENSE00003703874 | 102506695 | 102506824 |
| ENSE00003704976 | 102500699 | 102500793 |
| ENSE00003707246 | 102494538 | 102494675 |
| ENSE00003707430 | 102493825 | 102493969 |
| ENSE00003707758 | 102490986 | 102491123 |
| ENSE00003708219 | 102493116 | 102493285 |
| ENSE00003708340 | 102496140 | 102496204 |
| ENSE00003708457 | 102495278 | 102495390 |
| ENSE00003709858 | 102509599 | 102509660 |
| ENSE00003710080 | 102496469 | 102496619 |
| ENSE00003710090 | 102496847 | 102496964 |
| ENSE00003710614 | 102503163 | 102503244 |
| ENSE00003710682 | 102501096 | 102501227 |
| ENSE00003710870 | 102494881 | 102495073 |
| ENSE00003998262 | 102479976 | 102483713 |
| ENSE00003998263 | 102488463 | 102488598 |
| ENSE00003998265 | 102485039 | 102485159 |
| ENSE00003998266 | 102483825 | 102483889 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.27.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 96.27 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.14 | gold quality |
| muscle of leg | UBERON:0001383 | 95.26 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 95.07 | gold quality |
| muscle tissue | UBERON:0002385 | 91.00 | gold quality |
| pituitary gland | UBERON:0000007 | 89.96 | gold quality |
| right coronary artery | UBERON:0001625 | 89.85 | gold quality |
| endocervix | UBERON:0000458 | 89.60 | gold quality |
| mucosa of stomach | UBERON:0001199 | 89.36 | gold quality |
| fundus of stomach | UBERON:0001160 | 89.02 | gold quality |
| body of uterus | UBERON:0009853 | 89.01 | gold quality |
| adenohypophysis | UBERON:0002196 | 88.86 | gold quality |
| ectocervix | UBERON:0012249 | 88.58 | gold quality |
| myometrium | UBERON:0001296 | 88.39 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 88.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.85 | gold quality |
| right ovary | UBERON:0002118 | 87.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 87.51 | gold quality |
| tibial nerve | UBERON:0001323 | 87.45 | gold quality |
| skin of leg | UBERON:0001511 | 87.09 | gold quality |
| amygdala | UBERON:0001876 | 87.03 | gold quality |
| temporal lobe | UBERON:0001871 | 86.96 | gold quality |
| lower esophagus | UBERON:0013473 | 86.92 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 86.91 | gold quality |
| stromal cell of endometrium | CL:0002255 | 86.85 | gold quality |
| adipose tissue | UBERON:0001013 | 86.82 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 86.77 | gold quality |
| uterine cervix | UBERON:0000002 | 86.70 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.70 | gold quality |
| vagina | UBERON:0000996 | 86.50 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8410 | yes | 19.28 |
| E-GEOD-125970 | yes | 4.93 |
| E-ANND-3 | no | 1.70 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting RASA4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-4308 | 97.56 | 67.13 | 1385 |
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rasa4 | ENSDARG00000029372 |
| mus_musculus | Rasa4 | ENSMUSG00000004952 |
| rattus_norvegicus | Rasa4 | ENSRNOG00000001431 |
| drosophila_melanogaster | RasGAP1 | FBGN0004390 |
| drosophila_melanogaster | raskol | FBGN0261570 |
| caenorhabditis_elegans | WBGENE00001515 | |
| caenorhabditis_elegans | WBGENE00001516 |
Paralogs (10): RASAL2 (ENSG00000075391), RASAL3 (ENSG00000105122), RASA4 (ENSG00000105808), RASAL1 (ENSG00000111344), DAB2IP (ENSG00000136848), RASA1 (ENSG00000145715), RASA2 (ENSG00000155903), RASA3 (ENSG00000185989), NF1 (ENSG00000196712), SYNGAP1 (ENSG00000197283)
Protein
Protein identifiers
Ras GTPase-activating protein 4B — C9J798 (reviewed: C9J798)
All UniProt accessions (4): C9J798, A0A9L9PXW0, F5GXT2, F8W6L0
UniProt curated annotations — full annotation on UniProt →
Function. Ca(2+)-dependent Ras GTPase-activating protein, that may play a role in the Ras-MAPK pathway.
Subcellular location. Cytoplasm. Cytosol. Cell membrane.
Cofactor. Binds 3 Ca(2+) ions per C2 domain.
RefSeq proteins (2): NP_001264264, NP_001354696* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000008 | C2_dom | Domain |
| IPR001562 | Znf_Btk_motif | Conserved_site |
| IPR001849 | PH_domain | Domain |
| IPR001936 | RasGAP_dom | Domain |
| IPR008936 | Rho_GTPase_activation_prot | Homologous_superfamily |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR023152 | RasGAP_CS | Conserved_site |
| IPR035892 | C2_domain_sf | Homologous_superfamily |
| IPR037777 | RASA4_PH | Domain |
| IPR039360 | Ras_GTPase | Family |
Pfam: PF00168, PF00169, PF00616, PF00779
UniProt features (34 total): binding site 26, domain 4, chain 1, site 1, zinc finger region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9J798-F1 | 86.74 | 0.59 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 343 (arginine finger; crucial for gtp hydrolysis by stabilizing the transition state)
Ligand- & substrate-binding residues (26): 74; 74; 76; 76; 76; 79; 82; 82; 149; 149; 155; 202 …
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 46 (showing top):
GOLDRATH_IMMUNE_MEMORY, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, GOBP_RESPONSE_TO_METAL_ION, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION, TSENG_IRS1_TARGETS_DN, MORI_PRE_BI_LYMPHOCYTE_UP, GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION, GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION, BURTON_ADIPOGENESIS_9, GOBP_RESPONSE_TO_CALCIUM_ION, GOMF_ENZYME_ACTIVATOR_ACTIVITY
GO Biological Process (5): intracellular signal transduction (GO:0035556), negative regulation of Ras protein signal transduction (GO:0046580), cellular response to calcium ion (GO:0071277), regulation of intracellular signal transduction (GO:1902531), regulation of GTPase activity (GO:0043087)
GO Molecular Function (4): GTPase activator activity (GO:0005096), phospholipid binding (GO:0005543), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)
GO Cellular Component (4): cytosol (GO:0005829), plasma membrane (GO:0005886), cytoplasm (GO:0005737), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| intracellular anatomical structure | 2 |
| GTPase activity | 2 |
| signal transduction | 1 |
| Ras protein signal transduction | 1 |
| regulation of Ras protein signal transduction | 1 |
| negative regulation of small GTPase mediated signal transduction | 1 |
| response to calcium ion | 1 |
| cellular response to metal ion | 1 |
| regulation of signal transduction | 1 |
| intracellular signal transduction | 1 |
| regulation of hydrolase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| lipid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PCNA | RASA4B | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (5): RASA4B (Affinity Capture-MS), RASA4B (Affinity Capture-MS), RASA4B (Affinity Capture-MS), RASA4B (Affinity Capture-MS), RASA4B (Affinity Capture-MS)
ESM2 similar proteins: A0A0B4J1F4, A0A0G2JXN2, A2AWP8, A2RRH5, C9J798, O43374, O70277, O95294, P04629, P59926, Q0GA42, Q13368, Q14318, Q16512, Q29RM4, Q2HY40, Q2T9P3, Q2TBA3, Q5BIM1, Q5M7W1, Q5R5M3, Q5R811, Q5T7P8, Q5XIS9, Q62746, Q6PFQ7, Q6PFY8, Q7TNM2, Q7TP90, Q7Z4K8, Q8BG60, Q8BHT7, Q8BQC3, Q8C6N3, Q8CIW5, Q8IZ69, Q8NCT1, Q920N2, Q92546, Q925B4
Diamond homologs: A0AVI2, A0JJX5, A3KGK3, B2RUP2, C9J798, O43374, O95294, P48231, Q2WGJ9, Q54E35, Q5SPC5, Q8L706, Q8L7A4, Q8W4D4, Q9ERC5, Q9ESF1, Q9FVJ3, Q9HC10, Q9R189, Q9UT00, A0A075F932, A0FGR9, K8FE10, O00445, O35681, O43581, O94812, P04409, P05128, P10829, P13677, P21521, P21579, P21707, P24505, P24506, P24507, P29101, P34693, P40748
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3278 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:102483714:C:CC | acceptor_gain | 1.0000 |
| 7:102483888:CC:C | acceptor_gain | 1.0000 |
| 7:102483889:CC:C | acceptor_gain | 1.0000 |
| 7:102485032:GACTC:G | donor_loss | 1.0000 |
| 7:102485033:ACTCA:A | donor_loss | 1.0000 |
| 7:102485034:CTCAC:C | donor_loss | 1.0000 |
| 7:102485035:TCACC:T | donor_loss | 1.0000 |
| 7:102485036:CAC:C | donor_loss | 1.0000 |
| 7:102485037:A:AC | donor_gain | 1.0000 |
| 7:102485037:A:T | donor_loss | 1.0000 |
| 7:102485037:AC:A | donor_gain | 1.0000 |
| 7:102485038:C:CA | donor_loss | 1.0000 |
| 7:102485038:C:CC | donor_gain | 1.0000 |
| 7:102485038:CC:C | donor_gain | 1.0000 |
| 7:102485038:CCA:C | donor_gain | 1.0000 |
| 7:102485155:CTGAC:C | acceptor_gain | 1.0000 |
| 7:102485156:TGAC:T | acceptor_gain | 1.0000 |
| 7:102485157:GAC:G | acceptor_gain | 1.0000 |
| 7:102485158:AC:A | acceptor_gain | 1.0000 |
| 7:102485159:CC:C | acceptor_gain | 1.0000 |
| 7:102485160:C:CC | acceptor_gain | 1.0000 |
| 7:102485160:CTGG:C | acceptor_loss | 1.0000 |
| 7:102485167:C:CT | acceptor_gain | 1.0000 |
| 7:102488599:C:CC | acceptor_gain | 1.0000 |
| 7:102493111:CCCA:C | donor_gain | 1.0000 |
| 7:102493114:A:C | donor_loss | 1.0000 |
| 7:102493284:CT:C | acceptor_gain | 1.0000 |
| 7:102493286:C:CC | acceptor_gain | 1.0000 |
| 7:102493290:C:CT | acceptor_gain | 1.0000 |
| 7:102493295:C:CT | acceptor_gain | 1.0000 |
AlphaMissense
5223 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:102510258:A:G | W53R | 0.999 |
| 7:102510258:A:T | W53R | 0.999 |
| 7:102488493:A:G | W692R | 0.998 |
| 7:102488493:A:T | W692R | 0.998 |
| 7:102488577:A:G | W664R | 0.998 |
| 7:102488577:A:T | W664R | 0.998 |
| 7:102510256:C:A | W53C | 0.998 |
| 7:102510256:C:G | W53C | 0.998 |
| 7:102517671:C:A | G14W | 0.998 |
| 7:102501200:A:G | W180R | 0.997 |
| 7:102501200:A:T | W180R | 0.997 |
| 7:102511959:A:G | C30R | 0.997 |
| 7:102517671:C:G | G14R | 0.997 |
| 7:102517671:C:T | G14R | 0.997 |
| 7:102488491:C:A | W692C | 0.996 |
| 7:102488491:C:G | W692C | 0.996 |
| 7:102494620:G:T | A478D | 0.996 |
| 7:102501198:C:A | W180C | 0.996 |
| 7:102501198:C:G | W180C | 0.996 |
| 7:102509643:C:T | G85E | 0.996 |
| 7:102510263:G:T | P51H | 0.996 |
| 7:102511957:G:C | C30W | 0.996 |
| 7:102517670:C:T | G14E | 0.996 |
| 7:102488520:G:C | H683D | 0.995 |
| 7:102494598:G:C | F485L | 0.995 |
| 7:102494598:G:T | F485L | 0.995 |
| 7:102494600:A:G | F485L | 0.995 |
| 7:102503200:A:T | V158D | 0.995 |
| 7:102510200:A:T | V72D | 0.995 |
| 7:102510257:C:G | W53S | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1001461059 (7:102482212 C>G), RS1001492099 (7:102507216 G>A,T), RS1008378953 (7:102514776 AG>A), RS1009035682 (7:102508876 G>A,T), RS1009129184 (7:102486647 G>T), RS1009222167 (7:102480063 G>A,C), RS1010511456 (7:102511472 C>G), RS1010898674 (7:102487213 C>T), RS1014215422 (7:102480250 A>T), RS1014329662 (7:102480505 T>G), RS1019037384 (7:102508888 G>T), RS1019176035 (7:102486656 C>T), RS1020490724 (7:102487300 A>C), RS1020943352 (7:102511563 G>C), RS10227603 (7:102498268 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| sotorasib | affects cotreatment, decreases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| abrine | decreases expression | 1 |
| asparanin A | increases expression | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | decreases expression, affects cotreatment | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Glyphosate | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.